Why Nancy Pelosi’s Latest Move Has Stock Traders on Edge
Nancy Pelosi’s recent investment in Tempus AI Inc. has captured attention due to its potential in the precision medicine market. The precision medicine market is projected to reach $75.3 billion by 2031, highlighting significant growth opportunities. Despite its appeal, Tempus AI is